Brief: Cipla Receives USFDA Approval For First AB-Rated Generic Of Ventolin HFA
April 23 (Reuters) - Cipla Ltd CIPL.NS: RECEIVES USFDA APPROVAL FOR FIRST AB-RATED GENERIC OF VENTOLIN HFA TO LAUNCH GENERIC VENTOLIN HFA IN US IN H1 FY2026-27 Source text: ID:nBSE6Gs3WS Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated